This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....